acetazolamide

Generic: acetazolamide

Labeler: westminster pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler westminster pharmaceuticals, llc
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

acetazolamide 500 mg/1

Manufacturer
Westminster Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 69367-209
Product ID 69367-209_c04410c8-e55f-4f15-a10d-9d94476bde16
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090779
Marketing Start 2023-04-20
Marketing End 2028-05-01

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69367209
Hyphenated Format 69367-209

Supplemental Identifiers

RxCUI
562524
UPC
0369367209014
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA090779 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)
source: ndc

Packages (1)

69367-209-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)

Ingredients (1)

acetazolamide (500 mg/1)

Linked Drug Pages (1)

Acetazolamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c04410c8-e55f-4f15-a10d-9d94476bde16", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0369367209014"], "unii": ["O3FX965V0I"], "rxcui": ["562524"], "spl_set_id": ["417b1df2-63bc-473c-9e02-5f93dd45554d"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)", "package_ndc": "69367-209-01", "marketing_end_date": "20280501", "marketing_start_date": "20230420"}], "brand_name": "Acetazolamide", "product_id": "69367-209_c04410c8-e55f-4f15-a10d-9d94476bde16", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "69367-209", "generic_name": "Acetazolamide", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "500 mg/1"}], "application_number": "ANDA090779", "marketing_category": "ANDA", "marketing_end_date": "20280501", "marketing_start_date": "20230420"}